StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
H12.SI$2.20+0.00%
Fair $2.20+0.0%

H12.SI

Hotel Royal Limited

Consumer Cyclical / LodgingSES

$2.20

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $2.20Fund rank 26/100 · Data gapFallback financials|
SA 49/C
F-Score: 7/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-2.3M · quality 46.0/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 1.4%, below the 5% threshold
Thesis & Journal · H12.SILocal privado en este navegador · Hotel Royal Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$266M

P/E

27.5x

↑

EV/EBITDA

15.3x

↑

ROE

1.4%

↓

Gross Margin

46.4%

↑

Debt/Equity

0.21

↓
52-Week Range$2
$2$2

TradingView lightweight chart

H12.SI price, volumen y niveles de valoración

Último $2.200Periodo +32.1%
Fair value: $2.200

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+21.0%

FCF CAGR

—

FCF margin

16.2%

FCF / Net income

1.20x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $74.1M · net income $10.0M · FCF $12.0M

2022-FY → 2025-FY

Gross margin

46.4%+5.5% pts

Operating margin

22.1%+8.9% pts

Net margin

13.5%+21.7% pts

FCF margin

16.2%+20.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$74.1M$74.1M$66.8M$58.3M$41.9M
Net Income$10.0M$10.0M$6.7M$5.0M$-3.4M
EBITDA$26.5M$26.5M$24.5M$22.4M$9.9M
EPS——0.060.04-0.03
Gross Margin46.4%46.4%45.8%51.6%40.9%
Operating Margin22.1%22.1%21.7%21.3%13.3%
Net Margin13.5%13.5%10.0%8.6%-8.2%
Balance Sheet
Debt/Equity0.210.210.230.230.26
Current Ratio1.931.93———
Cash Flow
Free Cash Flow$12.0M$12.0M$-2.3M$-9.8M$-1.9M
Returns
ROE1.4%1.4%0.9%0.7%-0.5%
Valuation
P/E27.5027.5032.0144.58—
EV/EBITDA15.2615.2614.7416.4333.96
P/B0.360.360.300.330.31
Growth & Yield
Revenue Growth11.1%11.1%14.4%39.3%—
EPS Growth——33.3%223.9%—
Dividend Yield1.4%1.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +27.1%

Total return

+27.1%

Start / end P/E

n/dx → n/dx

EPS bridge

0.06 → n/d

Residual

+25.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.4%
Residual / FX / buybacks / cross-term+25.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.